Continuously updated topic dossier

Stem cells

Research involving stem cells and ageing-related outcomes.

Checking source freshness…
Automated evidence frame

Which cell products can safely restore function in defined tissues and patient groups?

How this is generated

Current evidence state

Evidence and authorization are highly product-, tissue-, and indication-specific; broad category claims are unreliable.

Known limits

Manufacturing, identity, potency, delivery, immune effects, tumour risk, and long-term follow-up are critical.

Regulatory context

Unapproved cell products may carry serious risks; verify the exact product and authorization with official regulators.

Building the latest evidence view…